Bank of America
SOPH icon

Bank of America’s SOPHiA GENETICS SOPH Stock Holding History

Bank of America’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,552
Closed -$25.9K – 6752
2025
Q4 		$25.9K Buy
+5,552
New +$25.2K ﹤0.01% 5997
2021
Q4 		– Sell
-3
Closed – – 8606
2021
Q3 		$0 Buy
+3
New +$53 ﹤0.01% 8373

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $369M AUM 45.79% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Bank of America's SOPH Position: Q1 2026 in Review

Bank of America sold out of SOPHiA GENETICS (SOPH) in Q1 2026, closing a stake of 5,552 shares — an estimated $25.9K sold.

Bank of America first reported a position in SOPH in Q3 2021 and held it in 2 quarters. The position peaked at $25.9K in Q4 2025. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.

  • Bank of America reported no remaining SOPHiA GENETICS position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 5,552 SOPHiA GENETICS shares in Q1 2026, an estimated $25.9K.
  • Bank of America first reported a position in SOPHiA GENETICS in Q3 2021 and held it in 2 quarters.
  • Bank of America's SOPHiA GENETICS position peaked at $25.9K in Q4 2025.
  • 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.